Log In
BCIQ
Print this Print this
 

Suprenza orally disintegrating tablets, phentermine

  Manage Alerts
Collapse Summary General Information
Company Citius Pharmaceuticals Inc.
DescriptionSympathomimetic amine anorectic
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationObesity
Indication DetailsTreat obesity
Regulatory Designation
PartnerAkrimax Pharmaceuticals LLC

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/15/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today